(3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)

C25H35F9N4O8 — CID 155836503

IUPAC(3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)
SMILESCn1ccnc1CN1CC[C@@H]2O[C@@H](COCCN3CCCC3)CC[C@@H]21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C19H32N4O2.3C2HF3O2/c1-21-11-7-20-19(21)14-23-10-6-18-17(23)5-4-16(25-18)15-24-13-12-22-8-2-3-9-22;3*3-2(4,5)1(6)7/h7,11,16-18H,2-6,8-10,12-15H2,1H3;3*(H,6,7)/t16-,17+,18+;;;/m1.../s1
InChIKeyFCWZGANDAJGWRI-MXQDYKHVSA-N
MW690.56 g/mol
LogP3.55
Rot. Bonds7

About (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)

(3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid) (PubChem CID 155836503) has the molecular formula C25H35F9N4O8 and a molecular weight of 690.56 g/mol. Its IUPAC name is (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name(3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)
PubChem CID155836503
Molecular FormulaC25H35F9N4O8
Molecular Weight690.56 g/mol
Exact Mass690.23
IUPAC Name(3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)
SMILESCn1ccnc1CN1CC[C@@H]2O[C@@H](COCCN3CCCC3)CC[C@@H]21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C19H32N4O2.3C2HF3O2/c1-21-11-7-20-19(21)14-23-10-6-18-17(23)5-4-16(25-18)15-24-13-12-22-8-2-3-9-22;3*3-2(4,5)1(6)7/h7,11,16-18H,2-6,8-10,12-15H2,1H3;3*(H,6,7)/t16-,17+,18+;;;/m1.../s1
InChIKeyFCWZGANDAJGWRI-MXQDYKHVSA-N
XLogP3.55
TPSA154.66 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms46
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500690.56
LogP ≤ 53.55
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)?
The IUPAC name of (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid) (CID 155836503) is (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid).
What is the SMILES notation for (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)?
The canonical SMILES for (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid) is Cn1ccnc1CN1CC[C@@H]2O[C@@H](COCCN3CCCC3)CC[C@@H]21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)?
The InChIKey is FCWZGANDAJGWRI-MXQDYKHVSA-N. The full InChI is InChI=1S/C19H32N4O2.3C2HF3O2/c1-21-11-7-20-19(21)14-23-10-6-18-17(23)5-4-16(25-18)15-24-13-12-22-8-2-3-9-22;3*3-2(4,5)1(6)7/h7,11,16-18H,2-6,8-10,12-15H2,1H3;3*(H,6,7)/t16-,17+,18+;;;/m1.../s1.
What are the key properties of (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid)?
(3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid) has a molecular weight of 690.56 g/mol, XLogP of 3.55, 7 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (3aS,5R,7aS)-1-[(1-methylimidazol-2-yl)methyl]-5-(2-pyrrolidin-1-ylethoxymethyl)-3,3a,5,6,7,7a-hexahydro-2H-pyrano[3,2-b]pyrrole;tris(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 155836503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).